Disclosure of pharmacokinetic drug results to understand nonadherence: results from a qualitative study

OBJECTIVES: In VOICE, a phase IIB trial of daily oral and vaginal tenofovir for HIV prevention, ≥50% of women receiving active products had undetectable tenofovir in all plasma samples tested. MTN-003D, an ancillary study using in-depth interviews (IDIs) and focus group discussions (FGDs), together...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:AIDS
Main Authors: VAN DER STRATEN, Ariane, MONTGOMERY, Elizabeth T., MUSARA, Petina, ETIMA, Juliane, NAIDOO, Sarita, LABORDE, Nicole, HARTMANN, Miriam, LEVY, Lisa, BENNIE, Thola, CHENG, Helen, PIPER, Jeanna, GROSSMAN, Cynthia I., MARRAZZO, Jeanne, MENSCH, Barbara
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4638164/
https://ncbi.nlm.nih.gov/pubmed/26544581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000000801
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares